Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors: Franziska Schaedeli; Maria Pitsiu; Neal L Benowitz; Steven G Gourlay; Davide Verotta
Journal: J Pharmacokinet Pharmacodyn Date: 2002-02 Impact factor: 2.745

3. Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.

Authors: Manthena V S Varma; Yurong Lai; Bo Feng; John Litchfield; Theunis C Goosen; Arthur Bergman
Journal: Pharm Res Date: 2012-05-26 Impact factor: 4.200

Review 4. Prediction of exposure-response relationships to support first-in-human study design.

Authors: John P Gibbs
Journal: AAPS J Date: 2010-10-22 Impact factor: 4.009

5. Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Authors: Sandhya Ramanathan-Girish; Juliet McColm; John M Clements; Phil Taupin; Sue Barrowcliffe; John Hevizi; Sharon Safrin; Clive Moore; Gary Patou; Heinz Moser; Alison Gadd; Ute Hoch; Vernon Jiang; Denene Lofland; Kirk W Johnson
Journal: Antimicrob Agents Chemother Date: 2004-12 Impact factor: 5.191

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Review 1. A time to die.

Review 2. THE ANALYSIS OF BIOLOGICAL SIMILARITY.

3. RELATIONSHIP OF LIVER COMPOSITION TO INTENSITY OF PROTEIN METABOLISM IN DIFFERENT MAMMALS.

4. Theory of biological similarity applied to some data of comparative physiology.

5. Metabolic turnover rate: a physiological meaning of the metabolic rate per unit body weight.

6. Scaling of renal functions in mammals.

Review 7. Scaling in biology: the consequences of size.

Review 8. Comparative drug metabolism.

9. On the space-time continuum in biology.

Review 10. Evolution of human longevity: a critical overview.

1. Allometric scaling of xenobiotic clearance: uncertainty versus universality.

2. Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation.

3. Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.

Review 4. Prediction of exposure-response relationships to support first-in-human study design.

5. Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Review 6. Population pharmacokinetic studies in pediatrics: issues in design and analysis.

7. A novel strategy for physiologically based predictions of human pharmacokinetics.

8. Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

9. Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator.

10. Acetaminophen in cerebrospinal fluid in children.